MYC and SLC7A5 constitute a feedback loop to amplify MYC transcriptional program, and sustain EAA metabolism in tumor cells.29 In principle, therapeutic targeting of SLC7A5 would offer an opportunity to unleash the functional association between MYC and SLC7A5, leading to tumor suppression. The gene discussed is SLC7A5; the disease is neoplasm.